EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Surgery for all patients with T1N0 non-small cell lung cancer?

Claudia Pouypoudat, Sébastien Thureau, Nicolas Giraud, Yaniss Belaroussi, Étienne Martin

Cancer/Radiothérapie · 2025

DOI: 10.1016/j.canrad.2025.104683 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer/Radiothérapie, 2025. Verfasst von Claudia Pouypoudat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Department, hôpital Haut-Lévêque, CHU de Bordeaux, 33200 Pessac, France. Electronic address: claudia.pouypoudat@chu-bordeaux.fr. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T1N0 non-small cell lung cancers account for about 20 % of all lung cancer cases and are defined as tumours up to 3cm without nodal or distant metastasis. The incidence of early-stage diagnoses is increasing, largely driven by the implementation of low dose computed tomography screening programs. Surgery has long been considered the standard of care for these tumours, offering excellent oncologic outcomes and allowing essential pathological staging. However, surgery may be indicated or poorly tolerated in certain populations, particularly elderly or medically inoperable patients. Stereotactic body radiotherapy has emerged as a non-invasive alternative with high local control rates and reduced early morbidity. This raises a critical question: should all patients with early-stage non-small cell lung cancer be managed surgically, or is there a role for treatment individualization? Current evidence highlights the need of balancing curative intent with treatment-related risks. Several clinical trials are currently evaluating stereotactic body radiotherapy in operable patients, aiming to identify subsets that may derive benefit from a non-surgical approach. This review advocates for a personalized, patient-centred treatment strategy, integrating tumour characteristics, operability, comorbidities, and patient preference.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansRadiosurgeryNeoplasm StagingPneumonectomyPrecision Medicine

Stichwörter der Autor:innen

CancerChirurgieLung cancerMédecine personaliséePersonalized medicinePoumonRadiotherapyRadiothérapieSurgery

Autor:innen und Institutionen

  • Radiation Oncology Department, hôpital Haut-Lévêque, CHU de Bordeaux, 33200 Pessac, France. Electronic address: claudia.pouypoudat@chu-bordeaux.fr.
  • Department of Radiotherapy, centre Henri-Becquerel, université de Rouen, Rouen, France.
  • Radiation Oncology Department, hôpital Haut-Lévêque, CHU de Bordeaux, 33200 Pessac, France.
  • Department of Thoracic Surgery, Hopital Haut Leveque, CHU de Bordeaux, Pessac, France.
  • Unicancer, Radiation Oncology Department, centre Georges-François-Leclerc, Dijon, France.

Zitieren

APA

Pouypoudat, C., Thureau, S., Giraud, N., Belaroussi, Y., & Martin, É. (2025). Surgery for all patients with T1N0 non-small cell lung cancer?. Cancer/Radiothérapie. https://doi.org/10.1016/j.canrad.2025.104683

Vancouver

Pouypoudat C, Thureau S, Giraud N, Belaroussi Y, Martin É. Surgery for all patients with T1N0 non-small cell lung cancer?. Cancer/Radiothérapie. 2025. doi:10.1016/j.canrad.2025.104683

BibTeX
@article{Pouypoudat2025,
  author = {Pouypoudat, Claudia and Thureau, Sébastien and Giraud, Nicolas and Belaroussi, Yaniss and Martin, Étienne},
  title = {Surgery for all patients with T1N0 non-small cell lung cancer?},
  journal = {Cancer/Radiothérapie},
  year = {2025},
  doi = {10.1016/j.canrad.2025.104683}
}
Kostenlos starten →